Merck Opens Application Phase for the 3rd Merck Accelerator China to Startups for Open Innovation
The Korea IT Times website reported that Merck has opened the first session for 2020 of applications for startup companies to participate in the global Merck Accelerator China program. Startups will cooperate with Merck experts at the company’s China Innovation Hub in Shanghai and sites in Guangdong, Beijing. Merck Innovation Hub China is committed
Comments Off on Merck Opens Application Phase for the 3rd Merck Accelerator China to Startups for Open Innovation • Read this story »
More Articles
Innovation in the Open
An article on the Chemistry World website noted a trend in open innovation: rather than drawing start-ups closer to obtain their intellectual property, some firms are shifting to a more collaborative approach. This strategy foresees collaboration agreements, or business support, and subsequent shared
Comments Off on Innovation in the Open • Read this story »
Is Open Innovation A Risk Worth Taking?
The Innovation Enterprise website noted that since the term was first coined in 2003 by Henry Chesbrough in his book ‘Open Innovation: The New Imperative,’ many organizations and governments have implemented Open Innovation programs to tremendous success. Open innovation works so well because
Comments Off on Is Open Innovation A Risk Worth Taking? • Read this story »
Open Innovation in Pharma
The PharmExecBlog notes that there are a number of highly innovative US companies that were at one time fully-integrated entities — companies that made mainframe computers, wrote the software, and sold you the paper on which to print. Essentially, they did everything from soup to nuts. That model
Open Innovation: Creating Through Community
An article on the crowdsourcing website draws lessons from Henry Chesbrough’s 2006 book “Open Business Models,” in which he describes a rising field of companies which specialize in innovation. He calls these companies “innovation intermediaries.” There are many kinds
Open Innovation to Fill Pharma’s Pipelines
The medcitynews website reported that open innovation and cooperation in the pharmaceutical industry will continue to gain traction as patent losses and R&D cutbacks force drug companies to look
Pharma Taking Open Innovation Medicine
The website Opinno notes that open innovation is the model that pharma companies are turning to now as a replacement to the traditional model which is based on developing R&D from their own basement laboratories, i.e, closed innovation. Once open innovation is adopted, the organization’s
R&D Execs Continue Global Search for Open Innovation
The FierceBiotech website reports that throughout 2011 there’s been a continuation of an intense reengineering of the development process at a slate of Big Pharma companies. Many of the Big Pharma companies have been pushing to reboot their own R&D programs. Perhaps the most exciting change